pharmaceuticals
Emerging markets
Mirabaud Asset Management's global equities manager Anu Narula has outlined his three best themes to plug into global growth and the economic recovery.
06 August 2013
•
UK
The death of blockbuster pharmaceutical companies has been greatly exaggerated by a market that is too focused on '0-60' stocks, according to Liontrust's Julian Fosh.
26 July 2013
•
Equities
The whole market has reached an inflection point and investors must now start to adapt to life without "massive stimulus", according to Psigma manager Bill Mott.
10 July 2013
•
Investment
Invesco Perpetual's head of investment Neil Woodford has begun building new positions in a number of businesses across his £25bn fund range over the past year.
07 June 2013
•
3 min read
Investment
Fidelity's Michael Clark has warned against buying into BP and Shell amid a dwindling oil price and ongoing issues for both businesses.
22 April 2013
•
2 min read
